New study argues the importance of existing anti-inflammatory drugs in fighting dementia
May 3, 2018Research and Development Alzheimer's, dementia, pharma
Research into dementia has waned in recent times as researchers struggle to pin down concrete advancements, leading to the withdrawal …
Recreational drug MDMA proves efficacy in reducing PTSD symptoms, new study finds
May 3, 2018Research and Development MDMA, PTSD, pharma
Promising new findings have been revealed in the efficacy of MDMA in treating post-traumatic stress disorder (PTSD).
Speakers Announced for Veeva R&D Summit, Europe
May 3, 2018Medical Communications biotech, drugs, pharma, pharmaceutical, veeva
In the pharma industry, we tend to use a lot of acronyms. Even in every day life, we are shortening …
Sandoz US woes continue with biosimilar rejection
May 3, 2018Sales and Marketing Novartis, Sandoz, biosimilars, biotech, drugs, pharma, pharmaceutical
In Novartis’ recently released Q1 results, which largely beat analysts’ estimates, Sandoz was a black spot on its record – …
450,000 missed breast cancer screenings, 270 lives potentially shortened
May 2, 2018Medical Communications Jeremy Hunt, NHS, UK, biotech, drugs, pharma, pharmaceutical
An error in the automated system left 450,000 women without an invite for breast screening and Jeremy Hunt, the UK’s …
BMS pulls the plug on Phase 3 trials of IDO1 inhibitor
May 2, 2018Research and Development BMS, Bristol-Myers Squibb, IDO1, opdivo, pharma, phase 3
Bristol-Myers Squibb has terminated two pivotal Phase 3 trials of BMS-986205, an IDO1 inhibitor acquired through its $800 million acquisition …
Samsung BioLogics’ shares down $6bn after accounting furore
May 2, 2018Research and Development, Sales and Marketing Samsung BioLogics, Samsung Bioepis, biotech, drugs, pharma, pharmaceutical, south korea
Samsung BioLogics’ shares have been hit hard, after the South Korean company was handed a notice of suspected breach of …
Startup CEO who injected untested herpes cure during live stream found dead
May 2, 2018Research and Development Aaron Traywick, Ascendance Biomedical, HIV, herpes, pharma
Aaron Traywick, the 28-year-old CEO of biotech startup Ascendance Biomedical who made headlines when he injected himself with an untested …
Novartis becomes first to gain second CAR T indication
May 2, 2018Research and Development, Sales and Marketing Gilead, Kymriah, Novartis, Yescarta, biotech, drugs, pharma, pharmaceutical
Novartis has announced that its CAR T treatment, Kymriah, has successfully been given a second indication for the treatment of …
Sanofi/Regeneron forced to slash price in wake of slow sales
May 1, 2018Research and Development, Sales and Marketing Regeneron, Sanofi, biotech, drugs, pharma, pharmaceutical, praluent
Sanofi and Regeneron were touted as having a sure-fire blockbuster on their hands when they first brought Praluent to market …
Takeda announces new UK MD, ahead of Shire transformation
May 1, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, Takeda, appointment, pharma
“Jon’s appointment comes at an exciting time for the company” reads the company press on annoucing its new Managing Director …
Porton Biopharma opens new leukaemia drug production facility
May 1, 2018Manufacturing and Production Porton Biopharma, leukaemia, pharma
Porton Biopharma Limited (PBL) has officially opened the doors of its new fermentation facility. John Glen, MP for Salisbury and …
Ovarian cancer rates set to rise by 55%
May 1, 2018Manufacturing and Production, Medical Communications biotech, drugs, ovarian cancer, pharma, pharmaceutical
Ahead of World Ovarian Cancer Day on 8 May, new figures have been released suggesting that rates of this type …
United Therapeutics to acquire SteadyMed for $216 million
May 1, 2018Manufacturing and Production, Sales and Marketing SteadyMed, UnitedTherapeutics, acquisition, pharma
United Therapeutics is set to acquire speciality pharma firm SteadyMed after it emerged that the pair had signed a definitive …
Novartis reveals more data for Eylea rival
May 1, 2018Manufacturing and Production, Research and Development biotech, drugs, pharma, pharmaceutical
Building on the back of strong data released at the end of last year, Novartis has released further positive Phase …
Lilly hires new leader of immuno-oncology
May 1, 2018Manufacturing and Production, Medical Communications Eli Lilly, biotech, drugs, immunoconlogy, immunotherapy, pharma, pharmaceutical
Immuno-oncology has become a huge area of the oncology market, led by the wave of PD-1/L1 drugs that are reaping …
Connecting patients to doctors
April 30, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
Dan Vahdat, CEO and Co-founder of Medopad, discusses the rapid expansion of the app he helped develop, as its mobile …
EMA’s CHMP backs Roche’s Perjeta combo in HER2-positive breast cancer
April 30, 2018Sales and Marketing Cancer, Herceptin, Perjeta, Roche, breast cancer, pharma
Roche’s Perjeta has edged one step closer to approval as a combo therapy after the EMA’s Committee for Medicinal Products …
Alzheon shies away from $81m IPO
April 30, 2018Sales and Marketing Alzheon, biotech, drugs, pharma, pharmaceutical
Alzheon, a tiny biotech based in the Boston area, had initially launched its roadshow for an IPO potentially worth up …
Allergan unveils second bout of Phase 3 success in migraine
April 30, 2018Research and Development, Sales and Marketing Allergan, migraine, pharma, ubrogepant
Allergan has revealed new data from the second of two Phase 3 studies into the efficacy of its calcitonin gene-related …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
